Respiratory Disease News and Research

RSS

ChatGPT outperforms trainee doctors in respiratory disease assessments

The chatbot ChatGPT performed better than trainee doctors in assessing complex cases of respiratory disease in areas such as cystic fibrosis, asthma and chest infections in a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

9 Sep 2024

RSV vaccine reduces illness and hospitalizations in adults over 60

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

5 Sep 2024

Selenium and manganese levels significantly impact mortality risk in asthma patients

Study reveals that both low and high levels of selenium and manganese in the blood are associated with increased mortality in adults with asthma, highlighting the importance of maintaining optimal levels of these metals.

5 Sep 2024

Exploring opioid prescription trends in chronic cough treatment

Chronic cough, with symptoms lasting more than eight weeks, affects approximately one in 10 adults. Cough is among the most common reasons for seeking medical care in the United States, yet chronic cough is difficult to treat. One of the largest studies of chronic cough and one of the first to explore the use of opioids, which are known to suppress cough, to treat these patients, has found that 20 percent of patients with chronic cough received a prescription for a cough suppressant containing an opioid.

23 Aug 2024

Coccidioidomycosis seasonal dynamics and their climate determinants in California

The study indicates that drought conditions suppress coccidioidomycosis seasonality. However, a transition from drought to wet conditions can lead to more pronounced seasonal peaks in California.

22 Aug 2024

How does the season of birth influence the risk of asthma and allergic rhinitis?

Finnish researchers report that season of birth likely impacts an individual’s future risk of developing airway allergy and related diseases.

20 Aug 2024

Finnish study links autumn and winter births to higher rates of asthma and allergic rhinitis

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland, a new registry-based study shows.

14 Aug 2024

Study uncovers OLAH as key driver of fatal respiratory disease

Respiratory infections can be severe, even deadly, in some individuals, but not in others.

12 Aug 2024

Korean researchers accelerate race for respiratory disease cures

The COVID-19 pandemic has profoundly impacted our lives, claiming nearly 7.1 million lives globally. Scientists and medical professionals have been working tirelessly to understand the virus, its transmission pathways, and effective treatments. The urgency of developing vaccines and treatments has never been greater, prompting calls for Korea to expedite its drug development efforts to match those of developed countries. Recently, a team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease research, garnering attention.

9 Aug 2024

Saliva test outperforms blood test in indicating the severity of recurrent respiratory infections in children

A saliva test can more accurately indicate the severity of recurrent respiratory infections in children than the standard blood test.

8 Aug 2024

Diabetes accelerates the onset of severe long-term conditions by 15-20 years, cutting life expectancy

A study in Nature Medicine reveals that diabetes accelerates the onset of multiple long-term conditions by 15-20 years, significantly reducing life expectancy in English adults.

4 Aug 2024

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of those suffering from respiratory disease, today announced dosing of the first person with cystic fibrosis (pwCF) in its Phase 2a trial of ETD001.

24 Jul 2024

COVID-19's impact on maternal mortality demands rethink of public health strategies

During the peak of the SARS-CoV-2 pandemic, there was an increase in maternal mortality in Chile. This is confirmed by a natural population experiment based on data from the Department of Health Statistics and Information (DEIS) of the Chilean Ministry of Health. The research was published in PLOS Global Public Health.

23 Jul 2024

Australian welders exposed to high levels of dangerous cancer-causing fumes, study reveals

New Curtin University research has revealed at least 46,000 Australian welders are exposed to high levels of dangerous, potentially cancer-causing fumes at work - and little is being done to protect them.

21 Jul 2024

Fruit flavored vapes and a nighttime dry cough - what's the connection?

Researchers examined the longitudinal association between exposure to electronic cigarette flavors and nocturnal dry cough.

2 Jul 2024

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Appointments bring additional respiratory and late clinical-stage drug development experience as Company commences Phase 2a clinical trial of its lead asset.

From Enterprise Therapeutics Ltd 17 Jun 2024

Heart-healthy habits keep you biologically young, study shows

A new study in the Journal of the American Heart Association reveals that heart-healthy lifestyle factors are linked to younger biological age and lower cardiovascular disease risk through DNA methylation.

29 May 2024

Heart healthy behaviors may slow biological aging, research shows

The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

29 May 2024

Study confirms face masks' effectiveness in reducing disease transmission, calls for improved public understanding

Researchers reviewed the benefits, practicalities, and harms of masks and masking, finding that masks are effective in reducing respiratory disease transmission despite some adverse effects, and emphasized the need for improved public understanding and policies.

23 May 2024

New Health Blueprint for Southwest Virginia highlights grave health challenges

A sweeping new Health Blueprint for Southwest Virginia highlights the grave health challenges that grip the rural region but also proposes solutions to help residents live longer, healthier lives.

20 May 2024